Valentina Echeverria received the Ph.D. degree with distinction in 1999 from the Department of Biological Sciences, University of Concepcion, Chile. The research was supported by a grant from CONICYT, granted to investigate the structure and function of the human Gsalpha protein, a cell signaling factor that couples to hundreds of membrane receptors. After obtaining the Ph.D. degree, Echeverria obtained a contract from the Science and Technology Ministry of Spain to work at the National Center of Biotechnology (CSIC), Madrid, Spain, (from 1999 to 2001). After this first postdoctoral experience, Echeverria moved to Montreal, Canada, to pursue a postdoctoral training in Alzheimer’s disease neuropathology at McGill University, under the direction of Dr. Claudio Cuello (from 2001 to 2003). Echeverria then accepted a postdoctoral position at Johns Hopkins University School of Medicine in Baltimore to work in the Anesthesiology and Critical Care Department under the direction of Dr. Sylvain Dore in characterizing new drugs against Stroke and Alzheimer’s disease pathology, using animal and neuronal models of neuroinflammation (from 2003 to 2005). Echeverria worked for one year (2005-2006) as a Scientist at Taub Institute for Research on Alzheimer's disease and the Aging Brain at the Department of Pathology, Columbia University, NY, USA, conducting research on molecular mechanisms of memory loss in Alzheimer’s disease. Echeverria moved to work at Bay Pines VA, Florida, USA, and became an Independent Scientist in 2007, focusing with the research team on the investigation of the pathological mechanisms underlying cognitive impairment in neurological and psychiatric conditions including Alzheimer’s disease, major depression, and posttraumatic stress disorder. They also work actively looking for new therapeutic drugs against these conditions.
Biography Updated on 9 January 2013